Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation

(2014) Torben Larsen et al.   THROMBOSIS AND HAEMOSTASIS

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

(2013) Sam Schulman et al.   CIRCULATION

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

(2013) T. van der Hulle et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis

(2013) L. A. Castellucci et al.   BMJ-British Medical Journal

New Antithrombotic Drugs

(2012) Jeffrey I. Weitz et al.   CHEST

Antithrombotic Therapy for VTE Disease

(2012) Clive Kearon et al.   CHEST

Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation

(2012) William L. Baker et al.  

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation

(2012) Jack Ansell et al.   THROMBOSIS AND HAEMOSTASIS

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis

(2012) L. H. Rasmussen et al.   BMJ-British Medical Journal

Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

(2012) B. D. Fox et al.   BMJ-British Medical Journal

Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor

(2011) Kan He et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

(2011) Pancras C. Wong et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor

(2009) Joachim Stangier et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE